Indication
Clostridium difficile colitis
5 clinical trials
6 products
1 drug
Clinical trial
Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection: A Randomized, Double-blind, Placebo-controlled TrialStatus: Recruiting, Estimated PCD: 2026-12-31
Product
Alanyl-glutamineClinical trial
A Multicenter Double Blind Randomized Study Comparing the Efficacy of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplantation (FMT) in the Management of Recurrent Clostridioides Difficile Infection (CDI)Status: Completed, Estimated PCD: 2024-03-12
Clinical trial
Fecal Microbiota Transplantation in Refractory Clostridium Difficile ColitisStatus: Recruiting, Estimated PCD: 2026-05-01
Product
Fecal MicrobiotaClinical trial
Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile InfectionStatus: Completed, Estimated PCD: 2023-07-06
Product
VancomycinDrug
VarlilumabClinical trial
A Prospective, Double-blind, Randomized, and Controlled Clinical Trial to Compare the Effectiveness of Intravenous Bezlotoxumab (10 mg/kg) Versus Placebo in Decreasing Morbidity and Mortality in Patients With Fulminant Clostridioides Difficile Requiring Surgical Intervention.Status: Terminated, Estimated PCD: 2022-05-23
Product
Bezlotoxumab